Targeted Strategies for Today's Evolving Markets

MissionIR Blog

InVivo Therapeutics Holdings Corp. (NVIV) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

InVivo Therapeutics Holdings is a medical device company focused on the development and commercialization of groundbreaking technologies for the treatment of spinal cord injuries (SCI). NVIV’s technologies encompass multiple strategies involving biomaterials, FDA-approved drugs, growth factors and human neural stem cells (hNSCs). The company’s platform technologies are also applied for the treatment of tumor removal, peripheral nerve damage, and postsurgical treatment of any transected nerve. For more information visit the company’s Web site at www.invivotherapeutics.com.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.

Let us hear your thoughts below:

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research and sales and trading services to institutional investors. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.
This entry was posted in Rodman and Renshaw Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *